MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.
about
Combining radiotherapy with sunitinib: lessons (to be) learnedPitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.A subpopulation of cancer stem cells identifies radiographic characteristics in glioblastoma.18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.Monitoring brain tumor vascular heamodynamic following anti-angiogenic therapy with advanced magnetic resonance imaging in mice.CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-SensitivIntratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRIHyperpolarized (13)C-lactate to (13)C-bicarbonate ratio as a biomarker for monitoring the acute response of anti-vascular endothelial growth factor (anti-VEGF) treatment.Imaging Tumor Vascularity and Response to Anti-Angiogenic Therapy Using Gaussia LuciferaseDICER governs characteristics of glioma stem cells and the resulting tumors in xenograft mouse models of glioblastomaMechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers.Recruitment of CD11b+Ly6C+ monocytes in non-small cell lung cancer xenografts challenged by anti-VEGF antibody.Dynamic Contrast-Enhanced Perfusion MRI of High Grade Brain Gliomas Obtained with Arterial or Venous Waveform Input Function.Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma.Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas.Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.Antiangiogenic Effect of Bevacizumab: Application of Arterial Spin-Labeling Perfusion MR Imaging in a Rat Glioblastoma Model.Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas.
P2860
Q26800587-FE58F556-A8ED-4076-B9CC-0BE56088C3B8Q30907831-2DA58790-5770-45A9-926F-A9EB1DE8D439Q33598907-A893C609-5185-4E1C-BBB4-D28EE36EC2ECQ35094941-7A90691E-9D86-494E-87AF-AD4EEAFE0576Q35519732-5929561E-D4F5-43E1-A206-928C902789A5Q35669792-3F839E8E-2FEF-4DC6-A5D8-0D91A1283365Q36082516-02AB3192-9CCD-4EB1-8946-6A3E11E4184FQ36578820-A002EADD-F017-45CA-A113-BB6B2272102DQ36803260-D7999A14-A227-4B29-89B9-DF3BA29BBF79Q36919260-6F8C2E2E-A8D1-4082-B7E6-51D56AEDD846Q37636641-784E0DB5-E049-49B6-840F-16FC76BE3885Q38786526-DEBDAB14-56F2-4466-B3FE-5FDB0867F5B6Q40978947-2204AC4E-63D3-4A39-BC9D-2F3D80857237Q41000474-E199A1C5-57FE-46FC-B5C6-04F8D8FEFE16Q41992449-6DF99C8E-DA7B-476E-9FA4-531F027DD19DQ48353619-01C7281D-68E4-42B6-A81C-B59B5304C802Q48525569-06577062-B4CF-4F5D-863B-C22AD673E894Q48541561-1A51F368-A050-40ED-A775-2FB028EC7A20Q48739694-179FAC3E-7546-4D5A-83F6-EB702A9FA90EQ52149377-50DF17FA-92A2-4761-AD8B-D7EAA1E17ED7
P2860
MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MRI biomarkers identify the di ...... me to anti-angiogenic therapy.
@ast
MRI biomarkers identify the di ...... me to anti-angiogenic therapy.
@en
type
label
MRI biomarkers identify the di ...... me to anti-angiogenic therapy.
@ast
MRI biomarkers identify the di ...... me to anti-angiogenic therapy.
@en
prefLabel
MRI biomarkers identify the di ...... me to anti-angiogenic therapy.
@ast
MRI biomarkers identify the di ...... me to anti-angiogenic therapy.
@en
P2093
P2860
P356
P1433
P1476
MRI biomarkers identify the di ...... me to anti-angiogenic therapy.
@en
P2093
Caroline Chung
Gelareh Zadeh
Kelly Burrell
Richard Hill
Sanjay Singh
Shahrzad Jalali
Warren Foltz
P2860
P304
P356
10.1093/NEUONC/NOU040
P577
2014-04-23T00:00:00Z